Pfizer 4Q Revenues: $16.7 billion (-4%) 4Q Earnings: $1.4 billion (-50%) FY Revenues: $67.4 billion (+1%) FY Earnings: $10.0 billion (+21%) Comments: U.S. revenues in the quarter were $6.3 billion (-12%). International revenues were $10.4 billion in the quarter (+3%). Results in the quarter reflect an operational decline of $765 million (-5%) and the favorable impact of foreign exchange of $157 million (+1%). Biopharmaceutical revenue was $14.1 billion in the quarter (-6%). Primary Care rev...